Iatrogenic Kaposi sarcoma presenting as retiform purpura during treatment of bullous pemphigoid
نویسندگان
چکیده
منابع مشابه
Classic Kaposi sarcoma presenting as elephantiasis nostras verrucosa
Kaposi sarcoma is a malignant disease that originates fromthe lymphatic system. Different epidemiological, clinical andhistopathological variants of this neoplasm have been identified.Classic Kaposi sarcoma is one of the four main clinico-epidemiologicvariants. Cutaneous lesions vary from pink patches to darkviolet plaques, nodules or polyps, depending on clinical variantand stage. Kaposi sarco...
متن کاملKaposi sarcoma presenting as severe haemoptysis.
Case report In spring 1995, a 36 year old HIV positive African man with CD4 count of 10 x 106/1 presented at Singleton Hospital with severe life threatening haemoptysis. Careful examination of the skin and oral cavity showed no evidence of Kaposi sarcoma (KS). On admission his investigations revealed a platelet count of 30 x 109/1 and a drop of 5 g/dl of haemoglobin to 6.8 g/dl compared with a ...
متن کاملA Case of Wolf's Isotopic Response Presenting as Bullous Pemphigoid
Vol. 29, No. 4, 2017 499 Received March 11, 2016, Revised July 25, 2016, Accepted for publication August 4, 2016 Corresponding author: Hwa Jung Ryu, Department of Dermatology, Korea University Ansan Hospital, 123 Jeokgeum-ro, Danwon-gu, Ansan 15355, Korea. Tel: 82-31-412-5186, Fax: 82-31-412-4208, E-mail: [email protected] This is an Open Access article distributed under the terms of the Creativ...
متن کاملBullous Pemphigoid Presenting with Esophagitis Dissecans Superficialis
An 87-year-old woman was admitted with a more than 6month history of an exacerbation of bullae. Edematous erythema and bullae were scattered throughout her extremities and trunk (Picture 1A). Serum autoantibodies against the BP-180 antigen were found. Histopathology confirmed a diagnosis of bullous pemphigoid (Picture 1B). She developed hematemesis on the fourth day after admission. Upper endos...
متن کاملBullous pemphigoid during ustekinumab therapy
BP: Bullous pemphigoid TNF-a: tumor necrosis factor-alfa INTRODUCTION Ustekinumab, a monoclonal antibody that blocks interleukin-12 and interleukin-23, is a biological therapy used to treat moderate-to-severe psoriasis. Bullous pemphigoid (BP) induced by antietumor necrosis factor-alfa (TNF-a) agents has been described in the literature. No cases have been reported with ustekinumab. We report a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JAAD Case Reports
سال: 2020
ISSN: 2352-5126
DOI: 10.1016/j.jdcr.2020.01.025